Director/PDMR Shareholding

RNS Number : 1377P

GlaxoSmithKline PLC

15 February 2016

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Vesting of Conditional Share Awards under the

GlaxoSmithKline Performance Share Plan

This notification sets out the vesting of awards over Ordinary Shares and American Depositary Shares ('ADS') in GlaxoSmithKline plc, made in 2013 to a Director's Connected Person and awards made in 2013 and 2014 to a Person Discharging Managerial Responsibility (PDMR) Connected Person under the GlaxoSmithKline 2009 Performance Share Plan. The awards were subject to relevant business performance conditions.

The three year performance period for the 2013 awards commenced on 1 January 2013 and ended on 31 December 2015.  The pro-rated two year performance period for the 2014 award began on 1 January 2014 and ended on 31 December 2015. 

The table below shows the proportion of these Performance Share Plan conditional awards that vested and lapsed on 12 February 2016.  This includes dividends accrued on the awards which vested in the same proportion, subject to performance, as the underlying shares.

Name of Director/PDMR	Name of Connected Person	Awards which have vested		Awards which have lapsed
		Ordinary Shares	ADS	Ordinary Shares	ADS
Dr M Slaoui*	Dr K Slaoui		897		1,479
Mr P Thomson	Mrs K Thomson	1,343		2,382

*denotes an Executive Director

The Company and the above individuals were advised of these transactions on 15 February 2016.

The closing share prices of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 12 February 2016 were £13.635 and US$39.76. 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

15 February 2016

 

END

 

 

RDSDELFFQLFEBBD